New Jersey's health care system continued to deliver services unevenly among racial groups, according to a study by a health care research group.

ASCEND Phase 1/2 global clinical trial ongoing, evaluating CR-001, a PD-1 x VEGF bispecific antibody, in multiple solid tumor ...

Astellas Pharma chief R&D officer Tadaaki Taniguchi at the Astellas Life Sciences Center in Cambridge, Massachusetts. Credit: ...

Structure Therapeutics Inc. (NASDAQ:GPCR) is one of the 10 best biotech stocks with highest upside potential. As of April 24 ...

Legend Biotech Corp. (NASDAQ:LEGN) is one of the 10 best biotech stocks with highest upside potential. On April 20, H.C.

Denali Therapeutics Inc. (NASDAQ:DNLI) is one of the 10 best biotech stocks with highest upside potential. On April 6, Denali ...

Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, announced today that it has entered ...

These six stocks pay dividend yields between 7% and nearly 12%. Find out who they are and why they have such generous ...

Corcept Therapeutics Inc. (NASDAQ: CORT) is one of the 10 best biotech stocks with highest upside potential.

Erasca has backed up bullish claims about its pan-RAS drug having a best-in-class profile, publishing phase 1 data that an ...

Young biotechs usually get acquired instead of profitably selling their own medicines. A growing number are proving they can, ...

North Carolina’s milestone of exceeding $230 million in biomanufacturing workforce training investments marks an ...